Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

NCT01517594 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 568

Last updated 2013-10-21

No results posted yet for this study

Summary

Confirmation of safety profile

Conditions

Sponsors & Collaborators

  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Clinical Development Support · Ferring Pharmaceuticals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01517594 on ClinicalTrials.gov